In a world with an increasing number of resistant and difficult-to-treat microbes, Pharma Holdings has set off to develop new drugs that are rapid acting and with a low propensity towards resistance development. Our new generation cationic peptide is the result of world-class research in the field of lytic peptides. Further, our compound LTX-109 is derived from a naturally occurring peptide which, together with the low drive towards resistance development, ensures a sustainable way of fighting off infections currently threatening the global health.
Company Details
- Employees
- 8
- Address
- Killengreensgate 2-8, Tromsø,9008,norway
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.pharmaholdings.no
- Keywords
- Engineer jobs.
- HQ
- Tromsø
Pharma Holdings As Questions
Pharma Holdings As's website is http://www.pharmaholdings.no
Pharma Holdings As's LinkedIn profile is https://no.linkedin.com/company/pharma-holdings-as
Pharma Holdings As has
8 employees.
View email and phone details for 8
employees at Pharma Holdings As.
Pharma Holdings As's industry is
Biotechnology Research
Pharma Holdings As's top competitors are
Mycotech Pharma As,
Nordic Pharma Inc As,
Pharma Holdings,
Calluna Pharma,
Arctic Pharma As,
Pharma Nordic As,
Mim Pharma,
Norsk Pharma As,
Pharma Marine As,
Lytix Biopharma.
Pharma Holdings As's categories are Biotechnology Research
